ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
129 hedge funds and large institutions have $467M invested in Achillion Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 43 increasing their positions, 44 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
129
Holders Change
-1
Holders Change %
-0.77%
% of All Funds
3.22%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
19
Increased
43
Reduced
44
Closed
18
Calls
$1.85M
Puts
$1.71M
Net Calls
+$135K
Net Calls Change
-$3.35M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$20.8M |
| 2 |
RI
RTW Investments
New York
|
+$7.3M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.77M |
| 4 |
Millennium Management
New York
|
+$5.03M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$4.97M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$7.41M |
| 2 |
SIM
Spark Investment Management
New York
|
-$2.36M |
| 3 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
-$2.1M |
| 4 |
MC
Marcus Capital
Northbrook,
Illinois
|
-$1.75M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$1.75M |
